Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05897099

Comprehensive HIV and Harm Prevention Via Telehealth

Led by University of Miami · Updated on 2026-02-17

350

Participants Needed

2

Research Sites

190 weeks

Total Duration

On this page

Sponsors

U

University of Miami

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

CONDITIONS

Official Title

Comprehensive HIV and Harm Prevention Via Telehealth

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Able to speak English or Spanish
  • Willing and able to sign informed consent, provide locator information, and medical records release
  • Negative rapid HIV test result
  • Used syringe services program to exchange syringes at least twice in the past 3 months
  • Planning to stay in the area for 12 months
Not Eligible

You will not qualify if you...

  • Positive reactive HIV test
  • Currently taking medications for opioid use disorder as confirmed by urine drug screen
  • Currently taking pre-exposure prophylaxis (PrEP) for HIV prevention by self-report
  • Excluded by principal or site investigator discretion
  • Currently in prison or jail
  • Currently enrolled in Clinical Trials Network 121
  • Received tele-harm reduction services in the previous 3 months
  • Showing signs or symptoms of acute HIV infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

IDEA Miami

Miami, Florida, United States, 33136

Actively Recruiting

2

IDEA Syringe Services Program

Miami, Florida, United States, 33136

Not Yet Recruiting

Loading map...

Research Team

H

Hansel Tookes, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Comprehensive HIV and Harm Prevention Via Telehealth | DecenTrialz